Pharmaceutical Industry News

Web

Images

News

News Home

BIOTECH AND PHARMA >> PHARMACEUTICAL INDUSTRY

Get our Pharmaceutical Industry daily Briefing

Biological sciences

Biotech

Genetics

Healthcare related

Human sciences

Pharmaceutical Industry

Photronics Down 7.8% Since SmarTrend's Sell Recommendation - 5 Hours ago

Since SmarTrend's Sell Recommendation TMC Launches New Sites :: EXPO Magazine UC Magazine NGN Magazine nology EXPO Show Daily Evolution Conference Summit Evolution Digium World Conference VoIP Forum :

all 112 news articles >>

Additional Pharma Competence Proposed for Diamyd Board of Directors - 4 Hours ago

- The shareholders of Diamyd Medical AB (publ) are summoned to the Annual General Meeting on Friday December 11, 2009 at 3:00 p.m. at the IVA Conference Center, Grev Turegatan 16 (Wallenberg auditorium)

all 1 news articles >>

Experts: Health care bills do nothing to lower costs - 3 Hours ago

WASHINGTON One of the White House's biggest boasts about the health care legislation now moving through Congress is that it should reduce health care costs for both government and society. Many prominent

all 22 news articles >>

Biosante Pharmaceuticals Down 4.8% Since SmarTrend's Sell Recomme... - 7 Hours ago

Company: BioSante Pharmaceuticals, Inc. (BPAX) SmarTrend, our proprietary pattern recognition system, called a Downtrend for Biosante Pharmaceuticals (NASDAQ:BPAX) on October 28, 2009 at $1.56. Since

all 10 news articles >>

ISTA Pharmaceuticals, Inc. (ISTA) Corporate Event Announcement No... - 8 Hours ago

ISTA Pharmaceuticals, Inc. (ISTA) Expected next earnings release: Announcement date: 2/18/2010 - After Market Earnings Quarter: Q4 Announcement Status: Unconfirmed Expected next investor conference call

Roche seeks broader EU breast cancer label for drug - 10 Hours ago

* EU approval sought for broader Avastin breast cancer use * Application based on study on benefits with chemotherapy ZURICH (Reuters) - Swiss drugmakerRoche Holding has filed for European approval to

all 2 news articles >>

Ernst & Young - The right transaction

Sponsored

The Preferred Rewards Gold Card takes you places. And shows you’ve arrived. Enjoy Gold Card benefits and access while you earn travel rewards fast. Earn 10,000 Membership Rewards® bonus points redeemable for rewards after your first purchase. Learn More

Managed IT Services Tailored to Needs of Biopharma - 7 Hours ago

Platform-as-a-Service (PaaS) offers IT efficiencies especially for emerging biopharma Just as biopharma companies are growing more comfortable with software-as-a-service (SaaS) for customer-relationship

Merck gets favourable judgement from US court against Flemings involving Fosamax - 7 Hours ago

Merck said that US District Court Judge John F Keenan granted summary judgement in Merck's favour in Flemings v Merck. Flemings is the second of three cases involving Fosamax (alendronate sodium) designated

AMR Research Selects 'Healthcare Top 25' for Supply Chain Excellence - 7 Hours ago

Fifteen of top 25 are drug or device makers; hospitals and distributors round out the list Saying that, by identifying 25 top-performing firms in delivering value across a supply chain from manufacturer

all 1 news articles >>

Business Line: BANKING/FINANCE: Asset-liability mismatch, a hitch in core sector - 6 Hours ago

Line: BANKING/FINANCE: Asset-liability mismatch, a hitch in core sector lending: Subbarao - Poten & Partners Username: Password: New user? Forgot your password? You are here: Business Line: BANKING/FINANCE:

all 2 news articles >>

Astellas Pharma Dropped US Lawsuit Against FDA Drug Decision (DJ) - 3 Hours ago

TOKYO -(Dow Jones)- Astellas Pharma Inc. (4503. TO) said Thursday it has withdrawn a suit against the U.S. Food and Drug Administration related to the use of generic versions of the company's immune system

all 1 news articles >>

Results of Annual General Meeting - 26 November 2009 - 4 Hours ago

Dear Sir, RE:RESULTS OF ANNUAL GENERAL MEETING - 26 NOVEMBER 2009 We are pleased to advise that the resolutions detailed below, which ...

all 6 news articles >>

CardioVascular BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals And - 4 Hours ago

Newly released report, CardioVascular BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile, provides detailed company analysis Published on November 26, 2009by Press Office(Companiesandmarkets.com

all 1 news articles >>

Progen Pharmaceuticals board changes - 2 Hours ago

Source: News Bites Progen Pharmaceuticals Ltd directors Gordon Schooley and Joe Yeh-Chiao Lin will resign at the general meeting to be held on November 30, 2009. The company recommends shareholders to

Pharmaceuticals: Researchers at Imperial College London, Department of Chemistry - 3 Hours ago

Today's Medical & Research News Pharmaceuticals Researchers at Imperial College London, Department of Chemistry release new data on pharmaceuticals November 26th, 2009 Printer-Friendly Version United

Pfizer Encourages Families to Take Their Dogs to Holiday Celebrations - 3 Hours ago

- 11/25/2009 Pfizer Animal Health wants families to talk with one another about bringing the family dog along when they travel to their Thanksgiving-to-New Year's celebrations. For most people, the holidays

Report on pain management pharmaceuticals market - 3 Hours ago

Pharma Unplugged: FDA Social Media Hearing - 3 Hours ago

Sponsored LinksPharmaceutical & Biotech conferences covering the entire pipeline from discovery to development, trials and marketing Eli Lilly uses SASÂ® to speed up clinical trials. Read more. Optimize

Serbia to call pre-qualification bid for drug firm - 3 Hours ago

BELGRADE (Reuters) - Serbia's Privatisation Agency said on Wednesday it would invite potential bidders by the end of the month to submit letters of intent to buy a controlling stake in drugmaker Galenika.